Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.

ABSTRACT:

Objectives

This study aimed to develop an evidence-based community pharmacist-delivered screening model for diabetes and cardiovascular disease (CVD), and assess its feasibility to identify and refer patients with elevated risk.

Design

A feasibility study.

Setting

A purposive sample of 12 community pharmacies in three cities in the United Arab Emirates (UAE).

Participants

Adults 40 years of age and above who have not been previously diagnosed with either diabetes or CVD.

Intervention

Pharmacist screening of adults visiting pharmacies involved history, demographics, anthropometric measurements, blood pressure and point-of-care testing including glycated haemoglobin (HbA1c) levels and lipid panel. Participants with a 10-year CVD risk ≥7.5%, HbA1c level ≥5.

SUBMITTER: Alzubaidi HT 

PROVIDER: S-EPMC6858145 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature